Back to results
US 10,377,778 B2Granted
Lead and thorium compounds
AssigneeSciencons AS
InventorRoy Hartvig Larsen
Life of this patent
Estimating the term…
Abstract
The present invention relates complexes comprising a PSMA targeting compound linked to a radionuclide, such as 212Pb or 227Th. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.
Claims13
A compound comprising a prostate specific membrane antigen (PSMA) binding unit and a chelating unit, wherein the PSMA binding unit is carbon-backbone linked to the chelating unit wherein the compound is:
Dependencies are inferred from the claim text.